Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 3, 2015
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Incentive Stock Option (right to buy)
2015-02-27+7,196→ 7,196 totalExercise: $13.90Exp: 2025-02-27→ Common Stock (7,196 underlying) - Purchase
Common Stock
2015-02-27$11.81/sh+800$9,452→ 29,552 total - Award
Non-Qualified Stock Option (right to buy)
2015-02-27+365,804→ 365,804 totalExercise: $13.90Exp: 2025-02-27→ Common Stock (365,804 underlying)
Footnotes (2)
- [F1]Includes shares acquired under the Sarepta Therapeutics, Inc. 2013 Employee Stock Purchase Plan; 674 shares were acquired on August 29, 2014 at a price of $19.4905 and 800 shares were acquired on February 27, 2015.
- [F2]25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.